Selinexor, Cyclophosphamide and Prednisone in Myeloma

Clinical trial NCT06212596 · COMPLETED

Trial details

NCT number: NCT06212596
Sponsor: University of Leeds
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma

Start date: 2018-07-16
Primary completion: 2022-10-25
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.